HomeMIRM • NASDAQ
Mirum Pharmaceuticals Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 111.59M | 61.20% |
Operating expense | 103.75M | 33.25% |
Net income | -14.68M | 41.94% |
Net profit margin | -13.15 | 63.99% |
Earnings per share | -0.30 | 44.44% |
EBITDA | -9.13M | 56.11% |
Effective tax rate | -7.54% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 277.67M | -8.31% |
Total assets | 690.25M | 5.87% |
Total liabilities | 456.99M | 9.50% |
Total equity | 233.26M | — |
Shares outstanding | 49.53M | — |
Price to book | 9.45 | — |
Return on assets | -5.58% | — |
Return on capital | -6.94% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -14.68M | 41.94% |
Cash from operations | -1.96M | -112.89% |
Cash from investing | -16.13M | -124,007.69% |
Cash from financing | 6.36M | 427.72% |
Net change in cash | -10.68M | -164.67% |
Free cash flow | -9.07M | -127.55% |
Previous close
$44.61
Day range
$43.50 - $44.66
Year range
$24.08 - $54.23
Market cap
2.20B USD
Avg Volume
393.45K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2018
Headquarters
Website
Employees
334
